Cardiac resynchronization therapy: a review of CRT-D versus CRT-P

Giuseppe Stabile1, Assunta Iuliano, Pietro Turco

  • 1Laboratorio di Elettrofisiologia, Clinica Mediterranea, Via Orazio 2, 80123 Napoli, Italy. gmrstabile@tin.it

Future Cardiology
|November 6, 2009
PubMed

Insights

Current guidelines suggest implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) for heart failure. A pragmatic approach favors CRT, with ICDs added based on individual clinical judgment to balance benefits against risks like inappropriate shocks.

Area of Science:

  • Cardiology
  • Medical Devices
  • Heart Failure Management

Background:

  • Current guidelines recommend implantable cardioverter-defibrillators (ICDs) for primary prevention of sudden cardiac death and cardiac resynchronization therapy (CRT) for symptom improvement in heart failure patients with reduced ejection fraction and ventricular conduction abnormalities.
  • Many patients may meet criteria for both ICD and CRT, raising questions about the added benefit of combined therapy.

Purpose of the Study:

  • To evaluate the pragmatic use of cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillators (ICDs) in heart failure management.
  • To provide a simplified approach to device selection for patients with New York Heart Association class III or IV heart failure.

Main Methods:

  • Review of current evidence-based guidelines and clinical practice recommendations.
  • Discussion of the potential benefits and risks of combined CRT and ICD therapy versus single-device therapy.
  • Proposal of a pragmatic approach prioritizing CRT with individualized consideration for ICD implantation.

Main Results:

  • Cardiac resynchronization therapy (CRT) is recommended for symptom improvement and survival in selected heart failure patients.
  • The addition of an implantable cardioverter-defibrillator (ICD) to CRT may not provide additional survival benefits for all patients.
  • The decision to add an ICD should be based on individual clinical judgment, weighing potential survival gains against risks such as inappropriate shocks.

Conclusions:

  • A pragmatic approach suggests prioritizing CRT for symptomatic heart failure (NYHA class III-IV) to improve quality of life and survival.
  • Implantable cardioverter-defibrillators (ICDs) may be added to CRT based on specific indications and clinical judgment.
  • The potential for increased morbidity from inappropriate shocks must be carefully considered when contemplating combined CRT and ICD therapy.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...